Moreover,studies targeting the tumor therapy target EGFR showed that kanamycinsignificantly enhanced the silencing effect of LNPs/siEGFR on EGFRmRNA and protein, suggesting its potential application in cancer genetherapy. The gene discussed is EGFR; the disease is neoplasm.